ROR1 and breast carcinoma: Li et al. reported that lncRNA MAYA (MST1/2-Antagonizing for YAP Activation) promoted breast cancer bone metastasis by activating ROR1-HER3 and Hippo-YAP pathways, which indicated important role of lncRNA in breast cancer bone metastasis [10].